(1 reference)-
- 抗原 See all IgM products
- IgM
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- FITC
-
应用范围
- Flow Cytometry (FACS)
- 产品特性
- Purified IgG conjugated to Fluorescein Isothiocyanate Isomer 1 (FITC)
- 克隆位点
- M15-8
- 亚型
- IgG1
-
Mouse anti-Human IgM antibody (FITC)
FACS Monoclonal CH2 IgG1 FITC
Mouse anti-Human IgM antibody (APC)FACS Monoclonal CH2 IgG1 APC
Goat anti-Human IgM antibody (Biotin)ELISA, FACS Polyclonal IgG Biotin F(ab')2 fragment
Mouse anti-Human IgM antibody (PE)FACS Monoclonal CH2 IgG1 PE
Mouse anti-Human IgM antibody (iFluor™647)GMP Grade FACS Monoclonal M-2E6 IgG1 iFluor™647
Mouse anti-Human IgM antibody (mFluor™450)GMP Grade FACS Monoclonal M-2E6 IgG1 mFluor™450
Mouse anti-Human IgM antibody (PE-Cy7)GMP Grade FACS Monoclonal M-2E6 IgG1 PE-Cy7
Goat anti-Human IgM antibody (FITC)ELISA, FACS Polyclonal IgG FITC F(ab')2 fragment
Goat anti-Human IgM (Heavy Chain) antibody (TRITC)ELISA, FACS, IHC Polyclonal IgG TRITC
Goat anti-Human IgM (Heavy Chain) antibody (FITC)ELISA, FACS, IHC Polyclonal IgG FITC
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 浓度
- 0.1 mg/mL
-
-
: "Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte ..." in: International journal of hematology, Vol. 91, Issue 3, pp. 501-8, (2010) (PubMed).
-
: "Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte ..." in: International journal of hematology, Vol. 91, Issue 3, pp. 501-8, (2010) (PubMed).
-
-
You are here:
